Cargando…
Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial
BACKGROUND: Korean Red Ginseng (KRG) is widely used for strengthening the immune system and fighting fatigue, especially in people with deficiency syndrome. However, there is concern that the long-term application or a high dose of KRG can cause “fireness” (上火 in Chinese) because of its “dryness” (燥...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823766/ https://www.ncbi.nlm.nih.gov/pubmed/31695571 http://dx.doi.org/10.1016/j.jgr.2019.05.006 |
_version_ | 1783464592768237568 |
---|---|
author | Zhang, Li Chen, Xiaoyun Cheng, Yanqi Chen, Qilong Tan, Hongsheng Son, Dongwook Chang, Dongpill Bian, Zhaoxiang Fang, Hong Xu, Hongxi |
author_facet | Zhang, Li Chen, Xiaoyun Cheng, Yanqi Chen, Qilong Tan, Hongsheng Son, Dongwook Chang, Dongpill Bian, Zhaoxiang Fang, Hong Xu, Hongxi |
author_sort | Zhang, Li |
collection | PubMed |
description | BACKGROUND: Korean Red Ginseng (KRG) is widely used for strengthening the immune system and fighting fatigue, especially in people with deficiency syndrome. However, there is concern that the long-term application or a high dose of KRG can cause “fireness” (上火 in Chinese) because of its “dryness” (燥性 in Chinese). The aim of this study was to assess the safety and efficacy of a 4-week treatment with KRG in participants with deficiency syndrome. METHODS: This was a 4-week, randomized, double-blind, placebo-controlled clinical trial. A total of 180 Chinese participants were randomly allocated to three groups: placebo control group, participants were given a placebo, 3.6 g/d; KRG 1.8 g and 3.6 g groups. The primary outcomes were the changes in fireness and safety evaluation (adverse events, laboratory tests, and electrocardiogram). The secondary outcomes were the efficacy of KRG on fatigue, which include the following: traditional Chinese medicine (TCM) symptom scale and fatigue self-assessment scale. RESULTS: Of the 180 patients, 174 completed the full study. After 4 weeks of KRG treatment, the Fire-heat symptoms score including Excess fire-heat score and Deficient fire-heat score showed no significant change as compared with placebo treatment, and no clinically significant changes in any safety parameter were observed. Based on the TCM syndrome score and fatigue self-assessment score, TCM symptoms and fatigue were greatly improved after treatment with KRG, which showed a dose- and time-dependent effect. The total effective rate was also significantly increased in the KRG groups. CONCLUSION: Our study revealed that KRG has a potent antifatigue effect without significant adverse effects in people with deficiency syndrome. Although a larger sample size and longer treatment may be required for a more definite conclusion, this clinical trial is the first to disprove the common conception of “fireness” related to KRG. |
format | Online Article Text |
id | pubmed-6823766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68237662019-11-06 Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial Zhang, Li Chen, Xiaoyun Cheng, Yanqi Chen, Qilong Tan, Hongsheng Son, Dongwook Chang, Dongpill Bian, Zhaoxiang Fang, Hong Xu, Hongxi J Ginseng Res Research Article BACKGROUND: Korean Red Ginseng (KRG) is widely used for strengthening the immune system and fighting fatigue, especially in people with deficiency syndrome. However, there is concern that the long-term application or a high dose of KRG can cause “fireness” (上火 in Chinese) because of its “dryness” (燥性 in Chinese). The aim of this study was to assess the safety and efficacy of a 4-week treatment with KRG in participants with deficiency syndrome. METHODS: This was a 4-week, randomized, double-blind, placebo-controlled clinical trial. A total of 180 Chinese participants were randomly allocated to three groups: placebo control group, participants were given a placebo, 3.6 g/d; KRG 1.8 g and 3.6 g groups. The primary outcomes were the changes in fireness and safety evaluation (adverse events, laboratory tests, and electrocardiogram). The secondary outcomes were the efficacy of KRG on fatigue, which include the following: traditional Chinese medicine (TCM) symptom scale and fatigue self-assessment scale. RESULTS: Of the 180 patients, 174 completed the full study. After 4 weeks of KRG treatment, the Fire-heat symptoms score including Excess fire-heat score and Deficient fire-heat score showed no significant change as compared with placebo treatment, and no clinically significant changes in any safety parameter were observed. Based on the TCM syndrome score and fatigue self-assessment score, TCM symptoms and fatigue were greatly improved after treatment with KRG, which showed a dose- and time-dependent effect. The total effective rate was also significantly increased in the KRG groups. CONCLUSION: Our study revealed that KRG has a potent antifatigue effect without significant adverse effects in people with deficiency syndrome. Although a larger sample size and longer treatment may be required for a more definite conclusion, this clinical trial is the first to disprove the common conception of “fireness” related to KRG. Elsevier 2019-10 2019-05-21 /pmc/articles/PMC6823766/ /pubmed/31695571 http://dx.doi.org/10.1016/j.jgr.2019.05.006 Text en © 2019 The Korean Society of Ginseng, Published by Elsevier Korea LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Zhang, Li Chen, Xiaoyun Cheng, Yanqi Chen, Qilong Tan, Hongsheng Son, Dongwook Chang, Dongpill Bian, Zhaoxiang Fang, Hong Xu, Hongxi Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial |
title | Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial |
title_full | Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial |
title_fullStr | Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial |
title_full_unstemmed | Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial |
title_short | Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial |
title_sort | safety and antifatigue effect of korean red ginseng: a randomized, double-blind, and placebo-controlled clinical trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823766/ https://www.ncbi.nlm.nih.gov/pubmed/31695571 http://dx.doi.org/10.1016/j.jgr.2019.05.006 |
work_keys_str_mv | AT zhangli safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial AT chenxiaoyun safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial AT chengyanqi safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial AT chenqilong safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial AT tanhongsheng safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial AT sondongwook safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial AT changdongpill safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial AT bianzhaoxiang safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial AT fanghong safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial AT xuhongxi safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial |